| ASSET | YEAR | % RETURN |
|---|---|---|
Immatics (IMTX) | 2018 | 195,900% |
Amerant Bancorp (AMTB) | 2018 | 17,462.12% |
Tandem Diabetes Care (TNDM) | 2018 | 1,515.74% |
Osisko Development (ODV) | 2018 | 1,327.44% |
Semler Scientific (SMLR) | 2018 | 358.67% |
Know Labs (KNW) | 2018 | 337.14% |
Xpel (XPEL) | 2018 | 326.68% |
CareDx (CDNA) | 2018 | 240.19% |
Amarin (AMRN) | 2018 | 239.4% |
Harrow Health (HROW) | 2018 | 234.71% |
Vericel Corp Ord (VCEL) | 2018 | 213.51% |
Tilray (TLRY) | 2018 | 206.03% |
Pacific Biosciences of California (PACB) | 2018 | 177.15% |
BlueLinx (BXC) | 2018 | 152.92% |
CorMedix (CRMD) | 2018 | 148.08% |
OPTIMIZERx (OPRX) | 2018 | 131.43% |
Acm Research (ACMR) | 2018 | 107.24% |
Kalvista Pharmaceuticals (KALV) | 2018 | 105.73% |
STAAR Surgical (STAA) | 2018 | 103.9% |
Vaalco Energy (EGY) | 2018 | 102.76% |
BioLife Solutions (BLFS) | 2018 | 100.5% |
SS Innovations International Inc Common Stock (SSII) | 2018 | 99.33% |
Sarepta Therapeutics (SRPT) | 2018 | 95.33% |
QuinStreet (QNST) | 2018 | 93.21% |
Zymeworks Inc Common Stock (ZYME) | 2018 | 90.9% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
